Regulus Therapeutics Inc.
(NASDAQ:
RGLS) shares dropped 12.57% to $14.74 in pre-market trading after the company reported top-line results from the 4 mg/kg cohort and additional results from the 2 mg/kg cohort in a completed clinical study evaluating RG-101.
Fifth Street Finance Corp. (NASDAQ:
FSC) shares declined 8.95% to $7.73 in pre-market trading. Fifth Street Finance reported a Q1 net loss of $30.7 million.
Himax Technologies, Inc. (NASDAQ:
HIMX) shares fell 5.30% to $7.52 in pre-market trading after dropping 4.45% on Friday.
Energy XXI Ltd. (NASDAQ:
EXXI) shares dropped 4.72% to $3.63 in pre-market trading after the company reported an adjusted loss of $0.35 per share for the fiscal second quarter.
Shire plc (NASDAQ:
SHPG) fell 2.32% to $218.46 in pre-market trading after dropping 2.08% on Friday.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
